AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Nov 14, 2012
30016_dirs_2012-11-14_c50ac5ba-ac1e-4f92-8b5c-5b12d605ce90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-11-12
Reporting Person: Williams Michael J PhD (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-12 | Common Stock | M | 12449 | $34.37 | Acquired | 19914 | Direct |
| 2012-11-12 | Common Stock | M | 2500 | $28.6550 | Acquired | 22414 | Direct |
| 2012-11-12 | Common Stock | M | 1294 | $28.6550 | Acquired | 23708 | Direct |
| 2012-11-12 | Common Stock | S | 12449 | $89.1335 | Disposed | 11259 | Direct |
| 2012-11-12 | Common Stock | S | 1294 | $89.1585 | Disposed | 9965 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-12 | Non-Qualified Stock Option (right to buy) | $34.37 | M | 12449 | Disposed | 2016-02-13 | Common Stock (12449) | Direct |
| 2012-11-12 | Incentive Stock Option | $28.6550 | M | 2500 | Disposed | 2015-02-02 | Common Stock (2500) | Direct |
| 2012-11-12 | Incentive Stock Option | $28.6550 | M | 1294 | Disposed | 2015-02-02 | Common Stock (1294) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $89.00 to $89.59, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $89.15 to $89.16, inclusive.
F3: Grant of options to buy shares of common stock becomes exercisable as to 4,149 shares on 02/14/2010, 4,150 shares on 02/14/2011, 4,150 shares on 02/14/2012, 4,149 shares on 02/14/2013, and the remaining 1,241 shares on 02/14/2014.
F4: Grant of options to buy shares of common stock becomes exercisable as to 1,074 shares on 02/03/2009 and the remaining 2,720 shares on 02/03/2010.